Filter
3243
Filtered Results: 3243
Text search:
burden
of
illness
Featured
Recommendations
295
New Publications
876
Language
Document type
No document type
1918
Studies & Reports
567
Guidelines
372
Manuals
140
Strategic & Response Plan
119
Training Material
45
Fact sheets
44
Situation Updates
18
Infographics
8
Resource Platforms
7
Brochures
5
Countries / Regions
India
169
Global
155
Kenya
112
South Africa
93
Ethiopia
76
Nigeria
69
Western and Central Europe
64
Uganda
63
Nepal
60
Liberia
59
Tanzania
53
Sierra Leone
52
Malawi
49
Africa
48
Zambia
47
Bangladesh
47
Latin America and the Carribbean
43
Ghana
42
Namibia
42
Rwanda
38
Myanmar / Burma
31
Syria
27
Ukraine
27
South–East Asia Region
25
Philippines
24
Lesotho
22
Eastern Europe
20
Zimbabwe
19
Cambodia
19
Asia
19
Mozambique
18
Botswana
15
East and Southern Africa
15
Congo, Democratic Republic of
14
South Sudan
14
Guinea
13
Eswatini/ Swaziland
12
Germany
11
Indonesia
11
Eastern Europe and Central Asia
11
USA
10
West and Central Africa
10
Russia
10
Haiti
9
Pakistan
9
Burkina Faso
7
Western Pacific Region
7
Cameroon
6
Thailand
6
Sudan
6
Brazil
6
Colombia
6
Middle East and North Africa
6
Venezuela
6
Senegal
5
Jordan
5
Afghanistan
5
Yemen
5
Albania
5
Somalia
4
Lebanon
4
Peru
4
Ecuador
4
Sri Lanka
4
Vietnam
4
Iraq
3
Turkey
3
China
3
Central African Republic
3
Burundi
3
Greece
3
Laos
3
Canada
3
Timor Leste/ East Timor
3
Moldova
3
North America
3
Jamaica
3
Mauritius
3
Mali
2
Egypt
2
Gambia
2
Papua New Guinea
2
Angola
2
Guatemala
2
Mexico
2
Southern Africa
2
Tajikistan
2
Romania
2
Georgia
2
Belarus
2
Côte d’Ivoire / Ivory Coast
1
Togo
1
Ireland
1
Benin
1
Hungary
1
Honduras
1
Chile
1
Other region
1
Paraguay
1
Poland
1
Palestine
1
Mongolia
1
Bulgaria
1
Lithuania
1
Slovakia
1
Kyrgyzstan
1
Kazakhstan
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
1247
Clinical Guidelines
285
Public Health
220
Women & Child Health
162
Key Resources
94
Capacity Building
51
Pharmacy & Technologies
22
Annual Report MEDBOX
1
Toolboxes
Mental Health
342
HIV
251
COVID-19
233
TB
221
Planetary Health
154
Disability
128
AMR
112
Caregiver
88
Rapid Response
81
Global Health Education
79
NCDs
69
NTDs
65
Conflict
63
Refugee
47
Ebola
46
Pharmacy
40
Natural Hazards
27
Health Financing Toolbox
22
Polio
17
Social Ethics
17
Cholera
16
Zika
12
Specific Hazards
11
South Sudan
1
Asthma is the most common noncommunicable disease in children, and among the most common in adults. According to the most recent estimates from the Global Asthma Network Phase I study, around one in 10 children and adults have symptoms of asthma and...
This brief report examines the extent to which community-based treatment and integration support are provided for people living with mental illness across 15 selected Asia-Pacific economies. Some of...
The meningitis road map has been designated as a flagship global strategy of the WHO’s Thirteenth General Programme of Work, 2019–2023 and is an essential component in achieving universal health...
Key questions
What is already known?
Critical illness is common throughout the world and COVID-19 has caused a global surge of critically ill patients.
There are large gaps in the quality...
The Coronavirus Disease 2019 (COVID-19) has had a continuous and robust impact on world health. The resulting COVID-19 pandemic has had a devastating physical, mental and fiscal impact on the millions of people living with noncommunicable diseases (...
Diabetes is a significant public health issue that affects approximately one in 10 adults globally, with type 2 diabetes accounting for 90–95% of cases. This chronic condition causes considerable morbidity and mortality and is growing in impact, w...
Infectious diseases cause over one billion human infections per year, with millions of deaths each year globally. Extensive health and financial burden is seen from both established and emerging inf...
Fever Diagnostic Technology Landscape
recommended
1st edition.
Unitaid’s report describes a slate of new devices that can more efficiently identify dangerously ill children so that they can be treated immediately. These tools make it easier to recognize danger signs, and support integrated appr...
Safe water, sanitation and hygiene (collectively known as WASH) are crucial for human health and well-being. Yet, millions of people globally lack adequate WASH services and consequently suffer from or are exposed to a multitude ... preventable illnesses.
Good primary care may lead to fewer avoidable hospitalizations, but unsafe primary care can cause avoidable illness and injury, leading to unnecessary hospitalizations, and in some cases, disability and even death.Implementing system changes and pra...
Clinical Microbiology and Infection Volume 21, Issue 5, May 2015, Pages 433-443;
The neglected zoonotic diseases (NZDs) have been all but eradicated in wealthier countries, but remain major causes of ill-health and mortality across Africa, Asia, a...
Cryptococcal disease, particularly cryptococcal meningitis is a significant cause of morbidity and mortality among people living with HIV with advanced HIV disease. It is estimated that it is responsible for nearly 19% ... AIDS-related mortality, second only to tuberculosis. Rapid screening, diagnosis and linking to appropriate treatment are critical actions national programs must take to reduce the burden of disease.
WHO in 2022 introduced updated guidelines for diagnosing, preventing, and managing cryptococcal disease among adults, adolescents and children living with HIV. This policy brief provides a summary of the key recommendations, clinical considerations, and also stresses the importance of ensuring access to life-saving antifungals. There is an urgent need for countries to scale-up management for not just cryptococcal meningitis, but address cryptococcal disease in the context of a package of care for advanced HIV disease as recommended by WHO.
Human Papilloma Virus (HPV) is the most common sexually transmitted infection, and two types of HPV (16 and 18) cause nearly 50% of high-grade cervical pre-cancers. HIV and cervical cancer are inext...
Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater and exacerbate...
For the primary health worker in a low/middle-income country (LMIC) setting, delivering quality primary care is challenging. This is often complicated by clinical guidance that is out of date, inconsistent and informed by evidence from high-income c...
Climate change presents the single biggest threat to human development, and its widespread impacts disproportionately burden the poorest and most vulnerable households in fragile and rural developing contexts – particularly women and children.
Ac...
Antimicrobials are medicines, including antibiotics, antivirals, antifungals, and antiparasitics, that are used to prevent and treat infections in humans, animals, and plants. Antimicrobial Resistance (AMR) arises when bacteria, viruses, fungi, and parasites no longer respond to these medicines, ren...
Global Development: Where Are We Now?
Today, we are facing a vital opportunity to change the profile of cardiovascular disease around the world.
The Millennium Development Goals (MDGs) are due to expire at the end ... 2015, placing the cardiovascular health community in a unique position to shape the priorities for the next development agenda, and save millions of lives.
Despite its devastating impact on people of all ages, genders and ethnicities, cardiovascular disease was excluded from the Millennium Development Goals (MDGs), which were announced by the United Nations in 2000. That oversight was far-reaching;
for well over a decade, non-communicable diseases were omitted from the global funding agenda and deprioritized by other mechanisms. During that period of muted government action, the prevalence and burden of non-communicable diseases increased in every region of the world.
Fifteen years later, as the successors to the MDGs are being negotiated, we are in a position to call for the prioritization of cardiovascular disease on the forthcoming global development agenda. Once we have ensured that CVD is recognised at the global policy level, our efforts will turn to encouraging governments to honour their commitments on
the prevention and control of CVD.
Adolescence, defined as the period between 10 and 19 years of age, is a developmental stage during which many psychosocial and mental health challenges emerge. There is a well-established link between mental health and HIV outcomes. Adolescents and ...
The COPSI project is divided into three phases: the first in which the intervention is developed, the second in which researchers evaluate the intervention in a randomised controlled trial, and the final one in which the results of the trial are ana...
